Recurrent T-Cell Prolymphocytic Leukemia
2 clinical trials · Condition
◉ Watch Recurrent T-Cell Prolymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia (NCT04526795) | M.D. Anderson Cancer Center | 2021-04-09 |
| Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia (NCT03989466) | M.D. Anderson Cancer Center | 2020-01-15 |
Track Recurrent T-Cell Prolymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.